Home / Market News / $CAH
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Morgan Stanley Raises Cardinal Health Price Target to $306

Nov 6, 2026, 4:04 PM UTC · Primary ticker $CAH

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health and increased its price target from $286 to $306. This adjustment reflects the firm's updated outlook on the company's performance, suggesting a positive sentiment from the analyst.

Morgan Stanley's analyst Erin Wright has raised the price target for Cardinal Health (CAH) from $286 to $306 while maintaining a Buy rating. This indicates a continued positive outlook on the company's future performance and financial prospects. For traders, this could signal short-term positive momentum for CAH as the market reacts to the analyst's upgraded valuation. Long-term implications depend on whether Cardinal Health's actual performance aligns with this increased price target, but it generally reinforces investor confidence. The primary affected party is Cardinal Health and its shareholders, who may see an uptick in stock value based on this analyst sentiment.

$CAH positive Price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.